Neogen (NEOG) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 18.16% |
| Nov 30, 2025 | -32.62% |
| Aug 31, 2025 | 29.69% |
| May 31, 2025 | -16.04% |
| Feb 28, 2025 | 3.53% |
| Nov 30, 2024 | 19.25% |
| Aug 31, 2024 | -37.78% |
| May 31, 2024 | 16.85% |
| Feb 29, 2024 | -35.26% |
| Nov 30, 2023 | 66.92% |
| Aug 31, 2023 | -2.54% |
| May 31, 2023 | 87.96% |
| Feb 28, 2023 | -33.19% |
| Nov 30, 2022 | -22.24% |
| Aug 31, 2022 | 40.90% |
| May 31, 2022 | -33.73% |
| Feb 28, 2022 | 22.40% |
| Nov 30, 2021 | -27.78% |
| Aug 31, 2021 | -15.49% |
| May 31, 2021 | 15.85% |
| Feb 28, 2021 | -58.50% |
| Nov 30, 2020 | 12.94% |
| Aug 31, 2020 | 25.33% |
| May 31, 2020 | 11.44% |
| Feb 29, 2020 | -29.80% |
| Nov 30, 2019 | 34.32% |
| Aug 31, 2019 | 5.77% |
| May 31, 2019 | -81.63% |
| Feb 28, 2019 | -79.14% |
| Nov 30, 2018 | 50.22% |
| Aug 31, 2018 | 36.16% |
| May 31, 2018 | 28.08% |
| Feb 28, 2018 | 17.11% |
| Nov 30, 2017 | 32.73% |
| Aug 31, 2017 | -32.80% |
| May 31, 2017 | 22.33% |
| Feb 28, 2017 | -45.96% |
| Nov 30, 2016 | -5.36% |
| Aug 31, 2016 | 28.68% |
| May 31, 2016 | -32.76% |
| Feb 29, 2016 | -26.67% |
| Nov 30, 2015 | 46.02% |
| Aug 31, 2015 | -242.89% |